XCSFDHG46767FHJHJF
tdp2664 E money daily Rite Aid (NYSE:RAD) has won the American Pharmacists Association’s Award for its 2011-12 Immunization Program. Rite Aid (NYSE:RAD) Wins Pharmacy Award Rite Aid (NYSE:RAD) has received the American Pharmacists Association’s Immunization Champion Award. The award recognizes Rite Aid (NYSE:RAD)’s Commitment to Pharmacist-Administered Vaccines. Robert I. Thompson, Rite Aid (NYSE:RAD) Executive Vice President of Pharmacy, said that, “Rite Aid (NYSE:RAD) made a company-wide commitment to boosting public immunization rates for flu and other vaccine-preventable diseases. It’s an honor to be recognized by our peers, American Pharmacists Association, for our efforts. I’d like to thank all Rite Aid (NYSE:RAD) pharmacists, as well as our store and corporate support teams, for making this valuable pharmacy service available to the communities Rite Aid (NYSE:RAD) serves". Rite Aid (NYSE:RAD) shares were at 1.59 at the end of the last day’s trading. There’s been a 37.4% change in the stock price over the past 3 months. Rite Aid (NYSE:RAD) Analyst Advice Consensus Opinion: Moderate Sell Mean recommendation: 3.33 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 3.33 Zack’s Rank: 2 out of 11 in the industry
No comments:
Post a Comment